Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Rain Oncology Inc. (RAIN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
   8-K10-K10-K
Revenues  61.40.00.0
Cost of goods sold  77.10.00.0
Gross profit  -15.70.00.0
            Gross margin  -25.6%  
Selling, general and administrative   [+]15.710.73.6
Research and development   40.815.4
Other operating expenses  45.7  
EBITDA   [+] -51.4-18.9
            EBITDA margin  -125.6%  
Depreciation and amortization   0.10.1
EBIT   [+]-77.1-51.5-19.0
            EBIT margin  -125.6%  
Interest income, net   [+] 0.10.2
Other income (expense), net   [+]1.40.0-2.3
Pre-tax income  -75.7-51.4-21.1
Income taxes  0.00.00.0
            Tax rate    0.0%
Net income  -75.7-51.4-21.1
            Net margin  -123.3%  
   
Basic EPS   [+]($2.71)($2.65)($6.29)
Diluted EPS   [+]($2.71)($2.65)($6.29)
   
Shares outstanding (basic)   [+]28.019.43.4
Shares outstanding (diluted)   [+]28.019.43.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy